Search

Your search keyword '"Lopez-Lopez R"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Lopez-Lopez R" Remove constraint Author: "Lopez-Lopez R"
130 results on '"Lopez-Lopez R"'

Search Results

4. Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials

6. Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and

9. Clinical outcomes of immunotherapy-based first-line regimens in advanced Renal Cell Carcinoma – the Onco-CHUS experience

15. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

21. 95P PAM50 HER2-enriched phenotype as a predictor of early response to neoadjuvant lapatinib plus trastuzumab HER2-positive breast cancer: Survival results of the SOLTI-PAMELA study

26. Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation

27. 1784P Activity of lurbinectedin in second-line SCLC patients candidates for platinum re-challenge

29. Combination of KIR2DS4 and Fc gamma RIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

30. Combination of KIR2DS4 and Fc gamma RII alpha polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (vol 9, 2589, 2019)

31. P-99 Circulating RNA detection, circulating tumor cells count, and molecular tumor profiling in a cohort of untreated metastatic colorectal cancer: A prospective multicenter ancillary study to the randomized VISNÚ trials

33. The quality oncology practice initiative program: Experience in Spain

34. Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project

36. PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system

37. Abstract LB-155: Identification of a DNA methylation signature in liquid biopsy for early non-small cell lung cancer (NSCLC) diagnosis

47. MOLECULAR PROFILING OF CIRCULATING TUMOR CELLS LINKS PLASTICITY TO THE METASTATIC PROCESS IN ENDOMETRIAL CANCER

48. Secreted factors derived from obese visceral adipose tissue regulate the expression of breast malignant transformation genes

Catalog

Books, media, physical & digital resources